Jeff Hall

New MRI research suggests that adjunctive AI may lead to a significant reduction of unnecessary prostate biopsies.

The FDA clearances include the 1.5T SIGNA Sprint with Freelium MRI platform, the 3T SIGNA Bolt MRI system and the AI-powered SIGNA One, which reportedly enhances MRI workflow efficiencies.

In a recent interview, Yulin Ge, M.D., discussed emerging research showing correlations between brain MRI findings in patients with Long Covid and established blood biomarkers for Alzheimer’s disease.

New research revealed that a “quadruple-low” radiation doing protocol with photon-counting CT provided significantly higher image quality and reduced contrast-induced nephropathy in comparison to energy-integrating detector CT (EID CT) for patients with lung cancer.

The Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System reportedly enables larger tissue samples and facilitates more efficiency in procedure setup and cleanup with 75 percent less tubing in comparison to other systems.

A machine learning model incorporating cardiac MRI and clinical data provided a 91 percent AUC for predicting major adverse cardiovascular events (MACE) in patients with STEMI, according to a new study involving over 1,000 patients and a median follow-up of 40 months.

Emphasizing improved quantification, the Kosmos POCUS platform now offers a biometric application for assessing fetal viability, measurements to facilitate evaluation of the uterus and ovaries, and enhanced reporting for vascular exams.

In comparison to 68Ga-PSMA-11, 64Cu-SAR-bisPSMA more than doubled the rate of detection for prostate cancer recurrence and facilitated changes to the treatment plan in 44 percent of patients, according to research to be presented at the upcoming European Association of Urology (EAU) Congress.

Sharing his perspective as well as insights from recently published research, Benjamin Kann, M.D., discussed the utility of AI foundation models for accessing an array of diagnostic and prognostic data from brain MRI scans.

Catch up on the top radiology content of the past week.

Total plaque volume > 87 mm3 derived from coronary computed tomography angiography (CCTA) was associated with double the risk for major adverse cardiovascular events (MACE), according to a study of over 4,200 symptomatic patients with an unknown history of coronary artery disease (CAD).

The use of the SPECT/CT agent 99mTc-maraciclatide may enhance detection and differentiation for interstitial lung disease, which is associated with a large variety of disorders.

Artificial intelligence scores > 73.5 percent for mammography were associated with over a threefold higher cumulative incidence rate for ipsilateral recurrence of DCIS in women treated with breast-conserving surgery, according to new research.

In a recent interview, Gary Ulaner, M.D., Ph.D., discussed preliminary research with the newly patented 61Cu-NU101 radiodiagnostic agent and the potential with the agent’s half-life in expanding access to molecular imaging for prostate cancer detection.

Employing digital breast tomosynthesis for biopsy guidance facilitated significantly lower radiation dosing than digital mammography guidance with no difference in malignancy rates, according to new research involving over 1,600 patients.

In a recent interview, Benjamin Kann, M.D., discussed new research highlighting the capability of an AI foundation model to obtain a variety of diagnostic and prognostic data from brain MRI scans.

For the detection of lung cancer on low-dose CT, the eyonis LCS software reportedly offers greater than 90 percent sensitivity, specificity and negative predictive value (NPV).

Researchers found that PSMA PET/CT offered 18 percent higher accuracy than mpMRI in detecting bilateral intraprostatic disease, according to a new study involving patients with intermediate or high-risk prostate cancer.

Catch up on the top radiology content of the past week.

Flagging DBT images that may warrant a more expedited review, the CogNet AI-MT+ platform can reportedly be integrated into existing IT systems to facilitate workflow efficiencies for radiologists.

In a recent interview from the International Stroke Conference, Jeremy Heit, M.D., Ph.D., discussed new research suggesting that AI may offer better assessment than neuroradiologists of aneurysm growth on computed tomography or magnetic resonance angiography scans.

The Ascent3T Neonatal Magnetic Resonance Imaging System is reportedly the first high-field 3T system geared to neonatal applications.

Wendie Berg, M.D., Stamatia Destounis, M.D., and Amy Patel, M.D., share their thoughts and perspectives on key findings from the Lancet mammography study on AI and interval breast cancer, and how they have incorporated AI into their practices.

A high SUVmean on PSMA PET imaging was associated with 95 more days of mean progression-free survival (PFS) in contrast to those with a low median SUVmean, according to a new study of patients with mCRPC treated with (225Ac)Ac-PSMA-I&T.

The CT-based RevealAI-Lung software reportedly offers a Malignancy Similarity Index score to facilitate evaluation of incidental lung nodules.

In addition to significantly reduced radiation dosing in comparison to energy-integrating detector CT (EID-CT), photon-counting CT provided higher detection of enhancement-related malignant features, according to new prospective research involving 200 patients with lung cancer.

The Brainomix 360 Stroke Next Generation software reportedly includes automated assessment of net water uptake (NWU), a CT-based biomarker that may improve risk stratification for patients with severe strokes.

In a recent interview, Amy Patel, M.D., discussed key targets in legislation for breast imaging in 2026 and offered advice for breast radiologists seeking to get more involved in advocacy.

The Allia Moveo C-arm platform reportedly offers ergonomic maneuverability, enhanced artifact reduction and flexibility with the use of cone-beam CT.

Catch up on the top radiology content of the past week.